Results 51 to 60 of about 367,353 (219)
Background We report an unusual case of a synchronous rectal and metachronous vaginal metastatic renal cell carcinoma. Case presentation A 78-year-old woman presented with hematochezia and a colonoscopy revealed a metastatic clear-cell renal cell ...
Simon Ouellet +4 more
doaj +1 more source
NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498 [PDF]
Background Recently, the anti-tumor activity of N-myc downstream-regulated gene 2 (NDRG2) was shown decreased expression in clear cell renal cell carcinoma (CCRCC), but the role of the down-expression of NDRG2 has not been described.
Jian-Jun Ma +5 more
core +1 more source
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
SUMMARY To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and ...
D. Clark +79 more
semanticscholar +1 more source
Simple Summary The aim of the present review is to discuss novel prognostic and therapeutic markers for clear cell renal cell carcinoma, a subtype of renal cell carcinoma which is the most common variant and is characterized by high aggressiveness ...
Valentina Schiavoni +8 more
semanticscholar +1 more source
Clear cell papillary renal cell carcinoma (CCP-RCC) is a recently described, relatively uncommon variant of renal cell carcinoma (RCC) with a reported incidence of 4.1%. Thought to only arise in those with end stage renal disease, CCP-RCC is increasingly
Heath Liddell +4 more
doaj +1 more source
Background: CIP2A has been proved to play a role as an oncogene in various types of malignancies while its functionality in renal clear cell carcinoma has not been investigated.
Hui Gao +4 more
doaj +1 more source
Liu F, Chen Y, Chen B, Liu C, Xing J. Cancer Manag Res. 2019;11:10891–10900. At the authors request, the Editor-in-Chief and Publisher of Cancer Management and Research wish to retract the published article.
Liu F, Chen Y, Chen B, Liu C, Xing J
doaj
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies [PDF]
A significantly increased level of the reactive oxygen species (ROS) scavenger glutathione (GSH) has been identified as a hallmark of renal cell carcinoma (RCC). The proposed mechanism for increased GSH levels is to counteract damaging ROS to sustain the
Meierhofer, David, Xiao, Yi
core +2 more sources
Multilocular Cystic Renal Cell Carcinoma: An Unusual Gross Appearance [PDF]
Multilocular Cystic Renal Cell Carcinoma (MCRCC) represents a rare variant of clear cell (conventional) renal cell carcinomas. Attributable to its distinct characteristics in prognosis and its natural history, MCRCC was recognised as a separate subtype ...
Jagtap, SV +3 more
core +1 more source
Gene amplification and overexpression of HER2 in renal cell carcinoma [PDF]
Objective To determine the frequency of HER2 genetic abnormalities in renal cell carcinoma (RCC) and hence assess the potential suitability of Herceptin(TM) immunotherapy.
Aitchison, M. +4 more
core +2 more sources

